Increasing Research and Development to Develop Therapeutic Solution for Chronic Diseases is expected to boost growth of Stem Cells Market Till 2020
“The Stem Cells Market size was valued at USD 37.88 billion in 2013 and is anticipated to raise at a CAGR of over 20.0% up to 2020.�
The global Stem Cells Market size is expected to reach USD 170.15 billion by 2020, according to a new report by Grand View Research, Inc. The market is expected to grow because of increasing research and development to develop therapeutic solution for chronic diseases and the huge funding by the government for drug discovery and development to serve the large unmet medical needs. Access Full Research Report on Global Stem Cells Market: http://www.grandviewresearch.com/industry-analysis/stem-cells-market The WHO statistics on Cancer (2012) concluded that it is the leading cause for global mortality and morbidity, with around 14 million new cancer cases and 8.2 million cancer related deaths which is estimated to reach 22 million in next two decades. Stem cells in combination with gene therapy along with DNA repair is anticipated to be used to treat many intractable diseases and is classified under orphan drugs.
Follow Us:
The California’s Stem Cell Agency has spent around USD 1.4 billion for stem cell research and still has USD 872 million to provide for the same. In addition to this, in 2013 the National Institute of Health has funded around USD1.3 million stem cell researches. Adult stem cell leads the market due to low contamination during sub-culture and expansion, relatively low labor production and compatibility with the human body. Induced pluripotent stem cells are expected to report revenue of over USD 4.5 billion by 2020, on account of analogous nature of its origin. Different types of technologies include cell acquisition, cryopreservation, cell production, expansion and sub-culture. For any technique in stem cell production, stem cell acquisition is the basic step; hence, this segment is likely to dominate the market with revenues estimated at USD 10.9 billion by 2020. Application of stem cell in regenerative medicines is exponentially increasing and hence dominates the market as compared to its application in drug discovery and medicine. Geographical presence of stem cell market is in North America, Asia Pacific, Europe and rest of the world. North America held the largest industry share due to huge government funding and initiative for stem cell research and rise in the acceptance of stem cell therapies. However, Asia-Pacific is expected to be the fastest growing segment with a CAGR of over 25.0% due to rising contract research outsourcing and medical tourism. Key industry contributors include Advanced Cell Technology Inc., CellartisAB, Cellular Engineering Technologies Inc., BioTime Inc. and International Stem Cell Corporation. In March 2015, International Stem Cell Corporation received patent from Japan for it human cell bank production from pathogenically activated eggs. This is in alignment with the companies’ strategy to make its intellectual property position strong and also develop relationship with Japan. Moreover, in June 2015, Cellaris AB launched a new xeno free culture called Cellartis EF-CS. Factors such as government funding, key player engagement to update the techniques, collaboration with domestic players for country specific market entry are expected to boom the stem cell market.
Follow Us:
Grand View Research has segmented the global stem cells market on the basis of product, application, technology and region: Read Our Blogs on Reports from this category By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare Table of Content of Global Stem Cells Market Research Report: Chapter 1. Executive Summary 1.1. Stem Cells - Industry Summary and Critical Success Factors (CSFs) Chapter 2. Stem Cells Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Stem Cells Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Stem Cells Market PESTEL Analysis, 2012 Chapter 3. Stem Cells Product Outlook 3.1. Adult Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.1. Hematopoietic Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.2. Mesenchymal Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.3. Neuronal Stem Cells Market Estimates and Forecasts, 2012 -
Follow Us:
2020 (USD Million) 3.1.4. Dental Stem Cells Market Estimates and Forecasts, 2012 2020 (USD Million) 3.1.5. Umbilical Cord Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.6. Human Embryonic Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.7. Induced Pluripotent Stem Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.8. Natural Rosette Cells Market Estimates and Forecasts, 2012 2020 (USD Million) 3.1.9. Very Small Embryonic Like Cells Market Estimates and Forecasts, 2012 - 2020 (USD Million) Chapter 4. Stem Cells Application Outlook 4.1.1. Regenerative Medicine Market Estimates and Forecasts, 2012 2020 (USD Million) 4.1.1.1. Neurology Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.2. Orthopedics Market Estimates and Forecasts, 2012 2020 (USD Million) 4.1.1.3. Oncology Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.4. Hematology Market Estimates and Forecasts, 2012 2020 (USD Million) 4.1.1.5. Cardiovascular and Myocardial Infraction Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.6. Injuries Market Estimates and Forecasts, 2012 - 2020
Follow Us:
(USD Million) 4.1.1.7. Diabetes Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.1.8. Liver Disorder Market Estimates and Forecasts, 2012 2020 (USD Million) 4.1.1.9. Incontinence Market Estimates and Forecasts, 2012 2020 (USD Million) 4.1.1.10. Others Market Estimates and Forecasts, 2012 - 2020 (USD Million) 4.1.2. Drug Discovery and Development Market Estimates and Forecasts, 2012 - 2020 (USD Million) Chapter 5. Stem Cells Technology Outlook 5.1. Cell Acquisition Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.1.1. Bone Marrow Harvest Market Estimates and Forecasts, 2012 2020 (USD Million) 5.1.2. Apheresis Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.1.3. Umbilical Blood Cord Market Estimates and Forecasts, 2012 2020 (USD Million) 5.2. Cell Production Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.2.1. Therapeutic Cloning Market Estimates and Forecasts, 2012 2020 (USD Million) 5.2.2. In Vitro Fertilization Market Estimates and Forecasts, 2012 2020 (USD Million) 5.2.3. Isolation Market Estimates and Forecasts, 2012 - 2020 (USD
Follow Us:
Million) 5.2.4. Cell Culture Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.3. Cryopreservation Market Estimates and Forecasts, 2012 - 2020 (USD Million) 5.4. Expansion and Sub-Culture Market Estimates and Forecasts, 2012 - 2020 (USD Million) Chapter 6. Stem Cells Regional Outlook 6.1. North America 6.1.1. Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 6.1.2. Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 6.1.3. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million) 6.2. Europe 6.2.1. Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 6.2.2. Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 6.2.3. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million) 6.3. Asia Pacific 6.3.1. Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 6.3.2. Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million)
Follow Us:
6.3.3. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million) 6.4. RoW 6.4.1. Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million) 6.4.2. Market Estimates and Forecasts, by Applications, 2012 - 2020 (USD Million) 6.4.3. Market Estimates and Forecasts, by Technology, 2012 - 2020 (USD Million) Chapter 7. Stem Cells Competitive landscape 7.1 Advanced Cell Technology Inc. 7.1.1 Company Overview 7.1.2 Financial Performance 7.1.3 Product Benchmarking 7.1.4 Strategic Initiatives 7.2 STEMCELL Technologies Inc. 7.2.1 Company Overview 7.2.2 Financial Performance 7.2.3 Product Benchmarking 7.2.4 Strategic Initiatives 7.3 Cellular Engineering Technologies Inc. 7.3.1 Company Overview 7.3.2 Financial Performance 7.3.3 Product Benchmarking 7.3.4 Strategic Initiatives 7.4 BioTime Inc. 7.4.1 Company Overview
Follow Us:
7.4.2 Financial Performance 7.4.3 Product Benchmarking 7.4.4 Strategic Initiatives 7.5 Cellartis AB 7.5.1 Company Overview 7.5.2 Financial Performance 7.5.3 Product Benchmarking 7.5.4 Strategic Initiatives 7.6 Angel Biotechnology 7.6.1 Company Overview 7.6.2 Financial Performance 7.6.3 Product Benchmarking 7.6.4 Strategic Initiatives 7.7 Bioheart Inc. 7.7.1 Company Overview 7.7.2 Financial Performance 7.7.3 Product Benchmarking 7.7.4 Strategic Initiatives 7.8 BrainStorm Cell Therapeutics 7.8.1 Company Overview 7.8.2 Financial Performance 7.8.3 Product Benchmarking 7.8.4 Strategic Initiatives 7.9 Celgene Corporation 7.9.1 Company Overview 7.9.2 Financial Performance 7.9.3 Product Benchmarking
Follow Us:
7.9.4 Strategic Initiatives 7.10 Osiris Therapeutics 7.10.1 Company Overview 7.10.2 Financial Performance 7.10.3 Product Benchmarking 7.10.4 Strategic Initiatives Chapter 8. Methodology and Scope 8.1. Research Methodology 8.2. Research Scope & Assumption 8.3. List of Data Sources About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: